These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23354091)

  • 21. Involvement of endothelial apoptosis underlying chronic obstructive pulmonary disease-like phenotype in adiponectin-null mice: implications for therapy.
    Nakanishi K; Takeda Y; Tetsumoto S; Iwasaki T; Tsujino K; Kuhara H; Jin Y; Nagatomo I; Kida H; Goya S; Kijima T; Maeda N; Funahashi T; Shimomura I; Tachibana I; Kawase I
    Am J Respir Crit Care Med; 2011 May; 183(9):1164-75. PubMed ID: 21239691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlates of osteoporosis in chronic obstructive pulmonary disease: An underestimated systemic component.
    Graat-Verboom L; Spruit MA; van den Borne BE; Smeenk FW; Martens EJ; Lunde R; Wouters EF;
    Respir Med; 2009 Aug; 103(8):1143-51. PubMed ID: 19304474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osteoporosis due to glucocorticoid use in children with chronic illness.
    Ward LM
    Horm Res; 2005; 64(5):209-21. PubMed ID: 16227699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of bone histology in the determination of bone metabolism].
    Barthel HR; Seibel MJ
    Med Klin (Munich); 2003 Feb; 98(2):111-2; author reply 113. PubMed ID: 12638546
    [No Abstract]   [Full Text] [Related]  

  • 25. Osteoporosis: on the verge of rational effective therapy?
    Bilezikian JP
    Mt Sinai J Med; 1993 Mar; 60(2):87-94. PubMed ID: 8469249
    [No Abstract]   [Full Text] [Related]  

  • 26. [Examination for osteoporosis in patients with chronic obstructive pulmonary disease].
    Johansen NJ; Harsløf T; Hermann AP; Andersen CU; Hilberg O; Løkke A
    Ugeskr Laeger; 2018 Oct; 180(40):. PubMed ID: 30274583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of bone for using of bone metabolic markers in the diagnosis and treatment of osteoporosis].
    Miura M
    Clin Calcium; 2013 Mar; 23(3):325-38. PubMed ID: 23445884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [POSSIBILITIES FOR COMPREHENSIVE LABORATORY EXAMINATION OF WOMEN WITH OSTEOPOROSIS ON AN OUTPATIENT BASIS].
    Larina VN; Raspopova TN; Bart BY
    Klin Med (Mosk); 2015; 93(3):21-6. PubMed ID: 26168599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Biochemical and immunological markers of osteoporosis in patients with chronic obstructive pulmonary disease].
    Kochetkova EA; Gel'tser BI; Semisotova EF; Volkova MV
    Klin Med (Mosk); 2002; 80(10):31-5. PubMed ID: 12471835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse effects of corticosteroids on bone metabolism: a review.
    Mitra R
    PM R; 2011 May; 3(5):466-71; quiz 471. PubMed ID: 21570035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Should COPD patients be routinely evaluated for bone mineral density?
    Karadag F; Cildag O; Yurekli Y; Gurgey O
    J Bone Miner Metab; 2003; 21(4):242-6. PubMed ID: 12811630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COPD and osteoporosis: links, risks, and treatment challenges.
    Inoue D; Watanabe R; Okazaki R
    Int J Chron Obstruct Pulmon Dis; 2016; 11():637-48. PubMed ID: 27099481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Not only a lung disease, but also a systemic disease. COPD as a threat to heart and bones].
    Wepner U
    MMW Fortschr Med; 2004 Apr; 146(18):4-5. PubMed ID: 15366457
    [No Abstract]   [Full Text] [Related]  

  • 34. Skeletal morbidity in inflammatory bowel disease.
    van Hogezand RA; Hamdy NA
    Scand J Gastroenterol Suppl; 2006; (243):59-64. PubMed ID: 16782623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osteoporosis in chronic obstructive pulmonary disease.
    Ionescu AA; Schoon E
    Eur Respir J Suppl; 2003 Nov; 46():64s-75s. PubMed ID: 14621108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Other systemic manifestations of chronic obstructive pulmonary disease.
    Stone AC; Nici L
    Clin Chest Med; 2007 Sep; 28(3):553-7, vi. PubMed ID: 17720043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention.
    Decramer M; Rennard S; Troosters T; Mapel DW; Giardino N; Mannino D; Wouters E; Sethi S; Cooper CB
    COPD; 2008 Aug; 5(4):235-56. PubMed ID: 18671149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Osteoporosis in chronic obstructive pulmonary disease].
    Pobeha P; Lazúrová I; Tkácová R
    Vnitr Lek; 2010 Nov; 56(11):1142-9. PubMed ID: 21250492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucocorticoid-induced osteoporosis: from basic mechanisms to clinical aspects.
    Alesci S; De Martino MU; Ilias I; Gold PW; Chrousos GP
    Neuroimmunomodulation; 2005; 12(1):1-19. PubMed ID: 15756049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteoporosis risk in patients with chronic obstructive pulmonary disease: the EOLO study.
    Maggi S; Siviero P; Gonnelli S; Schiraldi C; Malavolta N; Nuti R; Crepaldi G;
    J Clin Densitom; 2009; 12(3):345-52. PubMed ID: 19647671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.